TORONTO, ON / ACCESS Newswire / March 25, 2026 / NeuralCloud Solutions Inc. ("NeuralCloud"), a subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), is ...
Burnout and chronic fatigue carry a substantial economic cost and pose serious risks in professions where alertness is ...
Using artificial intelligence (AI) to analyze electrocardiograms (ECG) improved detection of severe heart attacks, including those that presented with unconventional symptoms, or atypical ECG patterns ...
Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield™ and CardioYield™. Reinforces competitive advantage as the Company advances ...
TORONTO, ON / ACCESS Newswire / November 24, 2025 / NeuralCloud Solutions Inc. ("Neural Cloud"), a subsidiary of AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), is ...
13d
HeartBeam (NASDAQ: BEAT) Partners with Mount Sinai to Accelerate AI-ECG Development and Validation
The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate high value, ...
Collaboration Expands Reach of MaxYield into Remote Heart Monitoring and Preventive Cardiology Applications TORONTO, ON / ACCESS Newswire / March 31, 2026 / AI/ML Innovations Inc. ("AIML" or the "Comp ...
BELFAST, Northern Ireland , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in AI-enabled cardiac diagnostics, today announced the closing of its seed funding round, led by Innovation ...
Atrial fibrillation (AF) represents a complex disorder of cardiac rhythm, deeply rooted in the intricate interplay between molecular, cellular, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results